Issue 24-4, 2025

Original article

Geriatric Rehabilitation with Diabetes Mellitus and Frailty: A Subanalysis of POSTSCRIPTUM Study



ORCIDNadezda K. Runikhina1, ORCIDIrina P. Malaya1, ORCIDYulia S. Onuchina1,*, ORCIDAlexandra V. Luzina1, ORCIDNatalia V. Sharashkina1, ORCIDValentina S. Ostapenko1, ORCIDElen A. Mkhitaryan1, ORCIDSergey N. Lysenkov1,2, ORCIDMariia S. Arefeva1, ORCID vgenii E. Popov1, ORCIDArina A. Arefieva1, ORCIDEkaterina N. Dudinskaya1, ORCIDYulia V. Kotovskaya1, ORCIDOlga N. Tkacheva1

1 Pirogov Russian National Research Medical University, Moscow, Russia
2 Lomonosov Moscow State University, Moscow, Russia


ABSTRACT

INTRODUCTION.  Functional activity and independence of elderly people with type 2 diabetes mellitus (DM2) depend not only on the glycaemic control, but also on the severity of geriatric syndromes. This subanalysis was conducted to study the peculiarities of the effect of individual geriatric rehabilitation (GR) programs on functional status in patients with type 2 DM2 and frailty.

AIM.  Evaluation of the effect of geriatric rehabilitation on the level of functional activity in patients with DM2 and frailty.

MATERIALS AND METHODS.  A subanalysis of data from POSTSCRIPTUM, a multicentre, prospective study, was conducted to evaluate the effectiveness of 21-day geriatric rehabilitation programmes for patients aged 60 years and over with senile asthenia syndrome. The subanalysis included 475 patients, who were divided into two groups: 91 patients with type 2 diabetes mellitus (DM2+ group) and 384 patients without DM (DM2– group). On visit 1, a comprehensive geriatric assessment (CGA) was performed, and a personalized 21 day GR program was developed. Visit 2 took place after the completion of GR to evaluate the effectiveness of the course.

RESULTS AND DISCUSSION.  The frequency of diagnosing geriatric syndromes (GS) and the distribution of frailty severity were comparable in the DM2+ and DM2– groups. Frailty was found in 38 % in the DM2+ group and 34 % in the DM2– group. Median age in the DM2+ and DM2– groups was 76 [71; 81.5] vs 80 [73; 84] years, p = 0.001. After the 3-week GR program, the DM2+ group showed an improvement in a brief battery of physical functioning tests (p < 0.001), an increase in the mean MoCA (Montreal Cognitive Assessment) score of 2.06 ± 0.38 (p < 0.001), a decrease in pain intensity in self-assessments according to the visual analog scale in the last week (p < 0.001), decreased insomnia severity index p = 0.03), and improved MNA (Mini Nutritional Assessment) score (p = 0.006). The subgroup of patients with preasthenia gravis additionally demonstrated improvements in baseline activities of daily living, nutritional status, and a decrease in the insomnia severity index.

CONCLUSION.  The POSTSCRIPTUM study demonstrated the effectiveness of short-term individualized GR programs based on CGA results in patients with DM2 and frailty in improving physical and cognitive status; pain severity; while the subgroup of patients with preasthenia gravis showed improvement in baseline activities of daily living, nutritional status, and a decrease in the insomnia severity index.

REGISTRATION:   Clinicaltrials.gov identifier No. NCT05740436, registered 23.02.2023.


KEYWORDS: diabetes mellitus type 2, frailty, comprehensive geriatric assessment, geriatric rehabilitation

FOR CITATION:

Runikhina N.K., Malaya I.P., Onuchina Y.S., Luzina A.V., Sharashkina N.V., Ostapenko V.S., Mkhitaryan E.A., Lysenkov S.N., Arefeva M.S., Popov E.E., Arefieva A.A., Dudinskaya E.N., Kotovskaya Y.V., Tkacheva O.N. Geriatric Rehabilitation with Diabetes Mellitus and Frailty: A Subanalysis of POSTSCRIPTUM Study. Bulletin of Rehabilitation Medicine. 2025; 24(4):32–43 https://doi.org/10.38025/2078-1962-2025-24-4-32-43 (In Russ.). 

FOR CORRESPONDENCE:

Yulia S. Onuchina, Е-mail: onuchina_ys@rgnkc.ru


References:

  1. Дедов И.И., Шестакова М.В., Викулова О.К. и др. Сахарный диабет в Российской Федерации: динамика эпидемиологических показателей по данным Федерального регистра сахарного диабета за период 2010–2022 гг. Сахарный диабет. 2023; 26(2): 104–123. https://doi.org/10.14341/DM13035 [Dedov I.I., Shestakova M.V., Vikulova O.K., et al. Diabetes mellitus in the Russian Federation: dynamics of epidemiological indicators according to the Federal Register of Diabetes Mellitus for the period 2010–2022. Diabetes mellitus. 2023; 26(2): 104–123. https://doi.org/10.14341/DM13035 (In Russ.).]
  2. Шестакова М.В., Викулова О.К., Железнякова А.В. и др. Сахарный диабет у лиц пожилого возраста: клинико-эпидемиологические характеристики всероссийской когорты пациентов старше 65 лет. Сахарный диабет. 2024; 27(6): 504–519. https://doi.org/10.14341/DM13261 [Shestakova M.V., Vikulova O.K., Zheleznyakova A.V., et al. Diabetes mellitus in the elderly: clinical and epidemiological characteristics of the all-Russian cohort of diabetic patients over 65 years. Diabetes mellitus. 2024; 27(6): 504–519. https://doi.org/10.14341/DM13261 (In Russ.)]
  3. Boccardi V., Bahat G., Balci C., et al. Challenges, current innovations, and opportunities for managing type 2 diabetes in frail older adults: a position paper of the European Geriatric Medicine Society (EuGMS)-Special Interest Group in Diabetes. Eur Geriatr Med. 2025. https://doi.org/10.1007/s41999-025-01168-1
  4. Russo G., Di Bartolo P., Candido R., et al. The AMD ANNALS: a continuous initiative for the improvement of type 2 diabetes care. Diabetes Res Clin Pract. 2023; 199: 110672. https://doi.org/10.1016/j.diabres.2023.110672
  5. Sinclair A.J., Abdelhafiz A.H., Rodríguez-Mañas L. Frailty and sarcopenia — newly emerging and high impact complications of diabetes. J Diabetes Complications. 2017; 31: 1465–1473. https://doi.org/10.1016/j.jdiacomp.2017.05.003
  6. Elmotia K., Abouyaala O., Bougrine S., Ouahidi M.L. Geriatric Syndromes in Older Adults with and Without Diabetes: A Systematic Review and Meta-Analysis. Res Gerontol Nurs. 2025; 18(2): 99–108. https://doi.org/10.3928/19404921-20250115-01
  7. Wong E., Backholer K., Gearon E., et al. Diabetes and risk of physical disability in adults: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2013; 1(2): 106–114. https://doi.org/10.1016/s2213-8587(13)70046-9
  8. Kong L.N., Lyu Q., Yao H.Y., et al. The prevalence of frailty among community-dwelling older adults with diabetes: A meta-analysis. International Journal of Nursing Studies. 2021; 119: 103952. https://doi.org/10.1016/j.ijnurstu.2021.103952
  9. Perkisas S., Vandewoude M. Where frailty meets diabetes. Diabetes Metab Res Rev. 2016; 32 Suppl 1: 261–267. https://doi.org/10.1002/dmrr.2743
  10. Hickman E., Gillies C., Khunti K., et al. Deprescribing, Polypharmacy and Prescribing Cascades in Older People with Type 2 Diabetes: A Focused Review. J Indian Inst Sci. 2023; 103: 191–204. https://doi.org/10.1007/s41745-022-00352-7
  11. Ткачева О.Н., Рунихина Н.К., Малая И.П. и др. Протокол клинического исследования ПОСТСКРИПТУМ: ПрОтокол гериатричеСкой реабилиТации при СтарчесКой астении у пациентов в возРасте 60 лет И старше в Пансионатах и сТационарных социальных Учреждениях г. Москвы. Многоцентровое проспективное исследование. Российский журнал гериатрической медицины. 2023; 1(13): 54–62. https://doi.org/10.37586/2686-8636-1-2023-54-62 [Tkacheva O.N., Runikhina N.K., Malaya I.P., et al. POSTSCRIPTUM: Protocol of Geriatric Rehabilitation in Patients Aged 60 Years and Older Living in Moscow Boarding houses or Nursing homes. Protocol of Multicentral Prospective Study. Russian Journal of Geriatric Medicine. 2023; 1(13): 54–62. https://doi.org/10.37586/2686-8636-1-2023-54-62 (In Russ.).]
  12. Ткачева О.Н., Рунихина Н.К., Малая И.П. и др. Гериатрическая реабилитация пациентов c синдромом старческой астении: промежуточные результаты открытого проспективного исследования «ПОСТСКРИПТУМ». Вестник восстановительной медицины. 2024; 23(6): 8–18. https://doi.org/10.38025/2078-1962-2024-23-6-8-18 [Tkacheva O.N., Runikhina N.K., Malaya I.P., et al. Geriatric Rehabilitation in Patients with Frailty: Interim Results of the POSTSCRIPTUM. An Open Prospective Study. Bulletin of Rehabilitation Medicine. 2024; 23(6): 8–18. https://doi.org/10.38025/2078-1962-2024-23-6-8-18 (In Russ.).]
  13. Ткачева О.Н., Фролова Е.В., Яхно Н.Н. и др. Гериатрия: национальное руководство. Москва: ГЭОТАР-Медиа. 2023; 720 с. [Tkacheva O.N., Frolova E.V., Yakhno N.N., et al. Geriatrics: national guideline. Moscow: GEOTAR-Media. 2023; 720 p. (In Russ.).]
  14. Дудинская Е.Н., Ткачева О.Н. Функциональный статус пожилого пациента с сахарным диабетом. Consilium Medicum. 2020; 22(4): 31–35. https://doi.org/10.26442/20751753.2020.4.200156 [Dudinskaya E.N., Tkacheva O.N. Functional status of an elderly patient with diabetes. Consilium Medicum. 2020; 22(4): 31–35. https://doi.org/10.26442/20751753.2020.4.200156 (In Russ.).]
  15. Egede L.E. Effect of comorbid chronic diseases on prevalence and odds of depression in adults with diabetes. Psychosom Med. 2005; 67(1): 46–51. https://doi.org/10.1097/01.psy.0000149260.82006.fb
  16. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под редакцией Дедова И.И., Шестаковой М.В., Майорова А.Ю. 11-й выпуск Москва. 2023; 236 с. https://doi.org/10.14341/DM13042 [Standards of specialized diabetes care. Edited by Dedov I.I., Shestakova M.V., Mayorov A.Yu. 11th Edition. Moscow. 2023. 236 p. (In Russ.).]
  17. Сычев Д.А., Ткачева О.Н., Котовская Ю.В., Малая И.П. Фармакотерапия у лиц пожилого и старческого возраста. Москва: Издательство ООО «КОНГРЕССХИМ». 2024; 124 с. [Sychev D.A., Tkacheva O.N., Kotovskaya Yu.V., Malaya I.P. Pharmacotherapy in the elderly and senile. Moscow: CONGRESSHIM Publishing House. 2024; 124 p. (In Russ.).]
  18. Cruz-Jentoft A.J., Sayer A.A. Sarcopenia. The Lancet. 2019; 393(10191): 2636–2646. https://doi.org/10.1016/s0140–6736(19)31138-9
  19. Cruz-Jentoft A.J., Bahat G., Bauer J., et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019; 48(1): 16–31. https://doi.org/10.1093/ageing/afy169
  20. Sinclair A.J., Laosa O., Antonio Carnicero J., et al. Disability and Quality of Life Measures in older frail and prefrail people with type 2 diabetes. The MIDFRAIL-Study. Diabetes Res Clin Pract. 2024; 214: 111797. https://doi.org/10.1016/j.diabres.2024.111797



Creative Commons License
The content is available under the Creative Commons Attribution 4.0 License.

©


This is an open article under the CC BY 4.0 license. Published by the National Medical Research Center for Rehabilitation and Balneology.